Subcutaneous cardiac stimulation device, system, and method providing accelerated arrhythmia detection verification and transient rate compensation

• US 7,546,159 B1
• Filed: 03/14/2005
• Issued: 06/09/2009
• Est. Priority Date: 03/14/2005
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Noren, Kjell, Farazi, Taraneh Ghaffari, Nabutovsky, Yelena, Bjorling, Anders
• Primary Examiner(s): Layno; Carl H.
• Assistant Examiner(s): MORALES, JON ERIC C
• Application Number:
  US11/080,215
• Time in Patent Office: 1,548 Days
• Field of Search: None
• US Class Current: 607/7
• CPC Class Codes: A61N 1/0504 Subcutaneous electrodes
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting

Abstract

A subcutaneous cardiac stimulation system verifies accelerated arrhythmia detection before delivering accelerated arrhythmia therapy to the heart. The stimulation system includes a verification circuit that verifies detection of the accelerated arrhythmia with each of first and second sense channels utilizing first and second electrode configurations. The therapy circuit delivers the stimulation therapy to the heart if the accelerated arrhythmia detection is verified with each of the first and second electrode configurations. The system also compensates for transient rate changes during the detection of the accelerated arrhythmia.

Claims

1. A subcutaneous cardiac stimulation system comprising:

an arrhythmia detector that detects an accelerated arrhythmia of a heart;

a subcutaneous lead system coupled to the arrhythmia detector and defining first and second arrhythmia detection electrode configurations;

a verification circuit that verifies detection of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations; and

a therapy circuit that delivers stimulation therapy to the heart responsive to verification of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit is responsive to a first detection of an accelerated arrhythmia with a first one of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit first verifies an accelerated arrhythmia detection with the first one of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit first verifies an accelerated arrhythmia detection with the first one of the first and second accelerated arrhythmia detection electrode configurations during a first verification time period following the first detection of the accelerated arrhythmia;

wherein the verification circuit further verifies the accelerated arrhythmia detection with both the first and second accelerated arrhythmia detection electrode configurations during a further verification period following the first verification period; and

wherein the verification circuit verifies the accelerated arrhythmia detection during the further verification period with a second one of the first and second accelerated arrhythmia detection electrode configurations providing continuous accelerated arrhythmia detection verification during a verification window within the further verification period.

2. The system of claim 1 wherein the verification window is a floating window.

3. The system of claim 1 wherein the further verification is completed upon continuous verification with the first one of the first and second accelerated arrhythmia detection electrode configurations up to completion of the verification window.

4. The system of claim 1 wherein the therapy circuit delivers the stimulation therapy to the heart following the further verification.

5. The system of claim 1 wherein the accelerated arrhythmia is ventricular fibrillation.

6. The system of claim 1 wherein the accelerated arrhythmia is ventricular tachycardia.

7. The system of claim 1 wherein the verification circuit verifies detection of an accelerated arrhythmia based upon heart rate.

8. A subcutaneous cardiac stimulation system comprising:

an arrhythmia detector that detects an accelerated arrhythmia of a heart;

a subcutaneous lead system coupled to the arrhythmia detector and defining first and second arrhythmia detection electrode configurations;

a verification circuit that verifies detection of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations; and

a therapy circuit that delivers stimulation therapy to the heart responsive to verification of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit is responsive to a first detection of an accelerated arrhythmia with a first one of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit selects a default one of the first and second accelerated arrhythmia detection electrode configurations as the first one of the first and second accelerated arrhythmia detection electrode configurations responsive to first accelerated arrhythmia detection with both the first and second accelerated arrhythmia detection electrode configurations;

wherein the verification circuit first verifies an accelerated arrhythmia detection with the first one of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit first verifies an accelerated arrhythmia detection with the first one of the first and second accelerated arrhythmia detection electrode configurations during a first verification time period following the first detection of the accelerated arrhythmia;

wherein the verification circuit further verifies the accelerated arrhythmia detection with both the first and second accelerated arrhythmia detection electrode configurations during a further verification period following the first verification period; and

wherein the verification circuit verifies the accelerated arrhythmia detection during the further verification period with a second one of the first and second accelerated arrhythmia detection electrode configurations providing continuous accelerated arrhythmia detection verification during a verification window within the further verification period.

9. The system of claim 8 wherein the verification window is a floating window.

10. The system of claim 8 wherein the further verification is completed upon continuous verification with the first one of the first and second accelerated arrhythmia detection electrode configurations up to completion of the verification window.

11. A subcutaneous cardiac stimulation system comprising:

an arrhythmia detector that detects an accelerated arrhythmia of a heart;

a subcutaneous lead system coupled to the arrhythmia detector and defining first and second arrhythmia detection electrode configurations;

a verification circuit that verifies detection of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations; and

a therapy circuit that delivers stimulation therapy to the heart responsive to verification of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit determines absence of asystole to verify detection of an accelerated arrhythmia.

12. A subcutaneous cardiac stimulation system comprising:

an arrhythmia detector that detects an accelerated arrhythmia of a heart;

a subcutaneous lead system coupled to the arrhythmia detector and defining first and second arrhythmia detection electrode configurations;

a verification circuit that verifies detection of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations; and

a therapy circuit that delivers stimulation therapy to the heart responsive to verification of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit measures myopotential on at least one of the electrode configurations.

13. A subcutaneous cardiac stimulation system comprising:

an arrhythmia detector that detects an accelerated arrhythmia of a heart;

a subcutaneous lead system coupled to the arrhythmia detector and defining first and second arrhythmia detection electrode configurations;

a verification circuit that verifies detection of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations; and

a therapy circuit that delivers stimulation therapy to the heart responsive to verification of an accelerated arrhythmia with each of the first and second arrhythmia detection electrode configurations;

wherein the verification circuit measures myopotential on each of the electrode configurations.

14. A method of verifying subcutaneous cardiac accelerated arrhythmia detection comprising:

confirming presence of the accelerated arrhythmia with a first subcutaneous sense channel during a first time period; and

confirming presence of the accelerated arrhythmia with the first subcutaneous sense channel and a second subcutaneous channel during a second time period following the first time period;

wherein the second recited confirming step includes confirming the presence of the accelerated arrhythmia with the second sense channel during a third time period within the second time period; and

wherein the third time period is a floating time period.

15. The method of claim 14 wherein the step of confirming the presence of the accelerated arrhythmia with the second sense channel includes confirming a continuous presence of the accelerated arrhythmia during the third time period.

16. The method of claim 14 wherein the steps of confirming each includes calculating cardiac rate and comparing the cardiac rate to a standard.

17. The method of claim 14 wherein the confirming steps include measuring myopotential on the first and second subcutaneous sense channels.

18. The method of claim 14 wherein the steps of confirming the presence of the accelerated arrhythmia with the first subcutaneous sense channel include confirming a continuous presence of the accelerated arrhythmia.

19. A method of verifying subcutaneous cardiac accelerated arrhythmia detection comprising:

confirming presence of the accelerated arrhythmia with a first subcutaneous sense channel during a first time period; and

confirming presence of the accelerated arrhythmia with the first subcutaneous sense channel and a second subcutaneous channel during a second time period following the first time period;

wherein the steps of confirming each includes determining an absence of asystole.